Nicotine (NC)-induced "depressive" behavioral symptoms and effects of antidepressants including cannabinoids (CBs)

Journal of Toxicological Sciences

Volumn 33, Issue 5, 2008, Pages 555-564

  Hayase, Tamaki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Antidepressants; Cannabinoids (CBS); Depressive behaviors; Immobilization stress; Nicotine (NC)

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CANNABINOID; CANNABINOID RECEPTOR; CLOMIPRAMINE; FLUVOXAMINE; NICOTINE; VIRODHAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DEPRESSION; FORCED SWIMMING TEST; IMMOBILIZATION STRESS; MALE; MOUSE; NONHUMAN;

EID: 57349139448     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.33.555     Document Type: Article

References (43)

1. Alves, S.H., Pinheiro, G., Motta, V., Landeira-Fernandez, J. and Cruz, A.P. (2004): Anxiogenic effects in the rat elevated plus-maze of 5-HT (2C) agonists into ventral but not dorsal hippocampus. Behav. Pharmacol., 15, 37-43.
2. Armario, A., Gil, M., Marti, J., Pol, O. and Balasch, J. (1991): Influence of various acute stressors on the activity of adult male rats in a holeboard and in the forced swim test. Pharmacol. Biochem. Behav., 39, 373-377.
3. Bambico, F.R., Katz, N., Debonnel, G. and Gobbi, G. (2007): Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J. Neurosci., 27, 11700-11711.
4. Boyer, C.S. and Petersen, D.R. (1992): Enzymatic basis for the transesterification of cocaine in the presence of ethanol: evidence for the participation of microsomal carboxylesterases. J. Pharmacol. Exp. Ther., 260, 939-946.
5. Brocco, M., Dekeyne, A., Veiga, S., Girardon, S. and Millan, M.J. (2002): Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents. Pharmacol. Biochem. Behav., 71, 667-680.
6. Castañé, A., Valjent, E., Ledent, C., Parmentier, M., Maldonado, R. and Valverde, O. (2002): Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology, 43, 857-867.
7. Compton, D.R. and Martin, B.R. (1997): The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. J. Pharmacol. Exp. Ther., 283, 1138-1143.
8. Consoli, D., Fedotova, J., Micale, V., Sapronov, N.S. and Drago, F. (2005): Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test). Eur. J. Pharmacol., 520, 100-107.
9. Costa, B., Giagnoni, G. and Colleoni, M. (2000): Precipitated and spontaneous withdrawal in rats tolerant to anandamide. Psychopharmacology (Berl.), 149, 121-128.
10. Devane, W.A., Dysarz, F.A. 3rd.., Johnson, M.R., Melvin, L.S. and Howlett, A.C. (1988): Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol., 34, 605-613.
11. Di Marzo, V., Griffin, G., De Petrocellis, L., Brandi, I., Bisogno, T., Williams, W., Grier, M.C., Kulasegram, S., Mahadevan, A., Razdan, R.K. and Martin, B.R. (2002): A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid. J. Pharmacol. Exp. Ther., 300, 984-991.
12. Felder, C.C., Briley, E.M., Axelrod, J., Simpson, J.T., Mackie, K. and Devane, W.A. (1993): Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. PNAS, 90, 7656-7660.
13. Fujishiro, J., Imanishi, T., Baba, J. and Kosaka, K. (2001): Comparison of noradrenergic and serotonergic antidepressants in reducing immobility time in the tail suspension test. Jpn. J. Pharmacol., 85, 327-330.
14. Gobbi, G., Bambico, F.R., Mangieri, R., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M.G., Debonnel, G., Duranti, A., Tontini, A., Tarzia, G., Mor, M., Trezza, V., Goldberg, S.R., Cuomo, V. and Piomelli, D. (2005): Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. PNAS, 102, 18620-18625.
15. González, S., Cascio, M.G., Fernández-Ruiz, J., Fezza, F., Di Marzo, V. and Ramos, J.A. (2002): Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res., 954, 73-81.
16. Hawkins, J. W. (1997): Antidepressant effects of nicotine. J. Clin. Psychiatry, 58, 324-325.
17. Hayase, T., Yamamoto, Y. and Yamamoto, K. (2000): Stress-related behavioral alterations accompanying cocaine toxicity: the effects of mixed opioid drugs. Jpn. J. Alcohol & Drug Dependence, 35, 402-414.
18. Hayase, T. (2007): Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs. BMC Neurosci., 8, 76.
19. Jiang, W., Zhang, Y., Xiao, L., Van Cleemput, J., Ji, S.P., Bai, G. and Zhang, X. (2005): Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J. Clin. Invest., 115, 3104-3116.
20. Kirch, D.G., Gerhardt, G.A., Shelton, R.C., Freedman, R. and Wyatt, R.J. (1987): Effect of chronic nicotine administration on monoamine and monoamine metabolite concentrations in rat brain. Clin. Neuropharmacol., 10, 376-383.
21. Lerman, C., Audrain, J., Orleans, C.T., Boyd, R., Gold, K., Main, D. and Caporaso, N. (1996): Investigation of mechanisms linking depressed mood to nicotine dependence. Addict. Behav., 21, 9-19.
22. Lopez-Valdes, H.E. and Garcia-Colunga, J. (2001): Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake. Mol. Psychiatry, 6, 511-519.
23. Mannucci, C., Tedesco, M., Bellomo, M., Caputi, A.P. and Calapai, G. (2006): Long-term effects of nicotine on the forced swimming test in mice: an experimental model for the study of depression caused by smoke. Neurochem. Int., 49, 481-486.
24. McLaughlin, P.J., Winston, K., Swezey, L., Wisniecki, A., Aberman, J., Tardif, D.J., Betz, A.J., Ishiwari, K., Makriyannis, A. and Salamone, J.D. (2003): The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behav. Pharmacol., 14, 583-588.
25. Morse, D.E. (1989): Neuroendocrine responses to nicotine and stress: enhancement of peripheral stress responses by the administration of nicotine. Psychopharmacology (Berl.), 98, 539-543.
26. Parrott, A.C. (2004): Heightened stress and depression follow cigarette smoking. Psychol. Rep., 94, 33-34.
27. Porsolt, R.D., Le Pichon, M. and Jalfre, M. (1977): Depression: a new animal model sensitive to antidepressant treatments. Nature, 266, 730-732.
28. Porter, A.C., Sauer, J.M., Knierman, M.D., Becker, G.W., Berna, M.J., Bao, J., Nomikos, G.G., Carter, P., Bymaster, F.P., Leese, A.B. and Felder, C.C. (2002): Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J. Pharmacol. Exp. Ther., 301, 1020-1024.
29. Renard, C.E., Dailly, E., David, D.J., Hascoet, M. and Bourin, M. (2003): Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test. Fundam. Clin. Pharmacol., 17, 449-455.
30. Rénéric, J.P. and Lucki, I. (1998): Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology (Berl.), 136, 190-197.
31. Romero, J., de Miguel, R., Garcia-Palomero, E., Fernandez-Ruiz, J.J. and Ramos, J.A. (1995): Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. Brain Res., 694, 223-232.
32. Shytle, R.D., Silver, A.A., Sheehan, K.H., Sheehan, D.V. and Sanberg, P.R. (2002): Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine. Depress. Anxiety, 16, 89-92.
33. Slawecki, C.J., Thorsell, A.K., El Khoury, A., Mathé, A.A. and Ehlers, C.L. (2005): Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior. Neuropeptides, 39, 369-377.
34. Stem, L., Chermat, R., Thierry, B. and Simon, P. (1985): The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl.), 85, 367-370.
35. Sun, B., Sterling, C.R. and Tank, A.W. (2003): Chronic nicotine treatment leads to sustained stimulation of tyrosine hydroxylase gene transcription rate in rat adrenal medulla. J. Pharmacol. Exp. Ther., 304, 575-588.
36. Tani, Y., Saito, K., Tsuneyoshi, A., Imoto, M. and Ohno, T. (1997): Nicotinic acetylcholine receptor (nACh-R) agonist-induced changes in brain monoamine turnover in mice. Psychopharmacology (Berl.), 129, 225-232.
37. Tizabi, Y., Overstreet, D.H., Rezvani, A.H., Louis, V.A., Clark, E.Jr., Janowsky, D.S. and Kling, M.A. (1999): Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology (Berl.), 142, 193-199.
38. Tritto, T., McCallum, S.E., Waddle, S.A., Hutton, S.R., Paylor, R., Collins, A.C. and Marks, M.J. (2004): Null mutant analysis of responses to nicotine: deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia. Nicotine Tob. Res., 6, 145-158.
39. Ushijima, K., Sakaguchi, H., Sato, Y., To, H., Koyanagi, S., Higuchi, S. and Ohdo, S. (2005): Chronopharmacological study of antidepressants in forced swimming test of mice. J. Pharmacol. Exp. Ther., 315, 764-770.
40. Van Dijken, H.H., Tilders, F.J., Olivier, B. and Mos, J. (1992): Effects of anxiolytic and antidepressant drugs on long-lasting behavioural deficits resulting from one short stress experience in male rats. Psychopharmacology (Berl.), 109, 395-402.
41. Vazquez-Palacios, G., Bonilla-Jaime, H. and Velazquez-Moctezuma, J. (2004): Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with flouxetine. Pharmacol. Biochem. Behav., 78, 165-169.
42. West, R.J., Hajek, P. and Belcher, M. (1989): Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol. Med., 19, 981-985.
43. Yu, Z.J. and Wecker, L. (1994): Chronic nicotine administration differentially affects neurotransmitter release from rat striatal slices. J. Neurochem., 63, 186-194.